Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exscientia PLC (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
EXAI
Nasdaq
8731
https://www.exscientia.ai/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exscientia PLC (ADR)
Exscientia Business and Financial Update for the Full Year 2023
- Mar 21st, 2024 11:00 am
Exscientia plc's (NASDAQ:EXAI) market cap touched US$797m last week, benefiting both individual investors who own 48% as well as institutions
- Mar 19th, 2024 10:25 am
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
- Mar 14th, 2024 11:00 am
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
- Mar 4th, 2024 8:49 pm
Exscientia to Present at Upcoming Investor Conferences in March
- Feb 28th, 2024 12:00 pm
Oxford drug company sacks chief executive over ‘inappropriate’ relationships with staff
- Feb 13th, 2024 6:13 pm
Exscientia fires CEO after probe over relationship with two employees
- Feb 13th, 2024 1:52 pm
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients
- Feb 7th, 2024 12:00 pm
The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs
- Jan 25th, 2024 6:06 pm
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
- Jan 2nd, 2024 1:09 pm
Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)
- Jan 2nd, 2024 12:00 pm
Ozempic drugmaker to open AI research hub in King’s Cross
- Dec 30th, 2023 5:00 pm
Wall Street Analysts See a 67.76% Upside in Exscientia PLC Sponsored ADR (EXAI): Can the Stock Really Move This High?
- Dec 21st, 2023 2:55 pm
Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme
- Dec 21st, 2023 12:00 pm
Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?
- Dec 14th, 2023 2:40 pm
Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now
- Dec 7th, 2023 1:15 pm
We Think Exscientia (NASDAQ:EXAI) Needs To Drive Business Growth Carefully
- Dec 6th, 2023 4:07 pm
Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza
- Dec 5th, 2023 12:00 pm
Wall Street Analysts Think Exscientia PLC Sponsored ADR (EXAI) Could Surge 68.03%: Read This Before Placing a Bet
- Dec 1st, 2023 2:55 pm
Is Dynavax Technologies (DVAX) Stock Outpacing Its Medical Peers This Year?
- Nov 24th, 2023 2:40 pm
Scroll